Skip to main content
Skip to main content
Header Nav
  • About
  • Products
  • Pipeline
  • Impact
  • Investors
  • Careers
  • Contact us
Investors Menu
Investor Relations
  • Investor Center Home
  • Press Releases
  • Corporate Governance
    • Board of Directors
    • Leadership Team
    • Policies and Charters
    • Board Committee Assignments
  • Stock Information
    • Stock Quote
    • Stock Chart
    • Historical Stock Quote
    • Investment Calculator
  • SEC Filings
  • Events & Presentations
  • Analyst Coverage
  • Investor FAQs
  • Contact IR

Press Releases

Press Releases

2022 2021 2020 2019 2018 2017 2016 2015 2014
Eagle Pharmaceuticals Provides 2022 Business Update and Announces Launch of Vasopressin
1/5/22
Eagle Pharmaceuticals to Present at the 40th Annual J.P. Morgan Healthcare Conference
1/3/22
Pagination
  • First page
  • Previous page
  • Page 1
  • Current page 2
Change % Volume Data as of 04/15/2022 1:08 AM EDT Data Provided by Refinitiv. Minimum 15 minutes delayed.
Investor Relations
  • Investor Center Home
  • Press Releases
  • Corporate Governance
    • Board of Directors
    • Leadership Team
    • Policies and Charters
    • Board Committee Assignments
  • Stock Information
    • Stock Quote
    • Stock Chart
    • Historical Stock Quote
    • Investment Calculator
  • SEC Filings
  • Events & Presentations
  • Analyst Coverage
  • Investor FAQs
  • Contact IR
Sidebar Links
  • Email Alerts
  • RSS Feeds

Investor Contact

In-Site
Communications, Inc.
Lisa M. Wilson,
212-452-2793

For all other media inquiries, please contact us.
Footer Links
  • privacy policy
  • terms of use
  • sitemap
  • contact us
© 2022 Eagle Pharmaceuticals, Inc. All rights reserved. Woodcliff Lake, NJ 07677